Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT00004998
What this trial is testing

Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT00518011
What this trial is testing

Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05646524
What this trial is testing

Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics 12
Post-approval studies (Phase 4)Study completedNCT03151551
What this trial is testing

Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Eli Lilly and Company 566
Large-scale testing (Phase 3)Study completedNCT00383578
What this trial is testing

Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 335
Not applicableLooking for participantsNCT07545317
What this trial is testing

Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

Who this might be right for
Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University 665
Testing effectiveness (Phase 2)Study completedNCT00925990
What this trial is testing

CTS-1027 in Interferon-Naive Hepatitis C Patients

Who this might be right for
Hepatitis C
Conatus Pharmaceuticals Inc. 70
Testing effectiveness (Phase 2)Study completedNCT00405821
What this trial is testing

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

Who this might be right for
HIV InfectionsHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 440
Not applicableStudy completedNCT00116415
What this trial is testing

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Who this might be right for
HIV InfectionsAIDS
Bristol-Myers Squibb 65
Early research (Phase 1)Study completedNCT00359190
What this trial is testing

Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 28
Post-approval studies (Phase 4)Looking for participantsNCT06913907
What this trial is testing

Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)

Who this might be right for
Rheumatoid Arthritis (RA)
Keio University 100
Testing effectiveness (Phase 2)UnknownNCT00474435
What this trial is testing

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Who this might be right for
TuberculosisHIV Infections
African Poverty Related Infection Oriented Research Initiative 30
Testing effectiveness (Phase 2)Study completedNCT01220947
What this trial is testing

Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 421
Testing effectiveness (Phase 2)Study completedNCT02337946
What this trial is testing

Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
Takeda 164
Testing effectiveness (Phase 2)Ended earlyNCT00234442
What this trial is testing

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

Who this might be right for
Brain NeoplasmsNon Small Cell Lung Cancer
AstraZeneca 47
Large-scale testing (Phase 3)UnknownNCT00954174
What this trial is testing

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Mixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more
GOG Foundation 637
Large-scale testing (Phase 3)Study completedNCT00158496
What this trial is testing

Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

Who this might be right for
Chronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 100
Large-scale testing (Phase 3)Study completedNCT00320359
What this trial is testing

Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 700
Not applicableStudy completedNCT00688454
What this trial is testing

C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

Who this might be right for
Hypercholesteremia
AstraZeneca 3,392
Large-scale testing (Phase 3)Study completedNCT02367794
What this trial is testing

Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]

Who this might be right for
Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,021
Next Page